Zoetis Inc - Class A

NYSE: ZTS
$159.70
+$1.28 (+0.8%)
Closing price April 29, 2024
Zoetis Inc. is a global leader in animal health, providing a wide range of medicines, vaccines, and diagnostic products for livestock and companion animals. With a focus on innovation, Zoetis serves veterinarians, livestock producers, and pet owners, offering solutions for diseases, parasites, and medical conditions across various species. The company, founded in 1952 and based in Parsippany, New Jersey, also explores new frontiers in animal health through collaborations, including efforts to develop novel antibiotics.
Source: Jon Ogg2013 has felt a bit slow in the world of initial public offerings as we have not had that many initial public offerings come from major companies with such a strong stock market. That...
Source: Jon OggThese are some of the top analyst upgrades, downgrades and reiterations seen by 24/7 Wall St. from the key Wall St. research calls this Wednesday.Boeing Co. (NYSE: BA) reiterated Buy...
U.S. equity markets opened higher this morning on the heels of a solid report on U.S. nonfarm payrolls, which rose less than expected but on top of a large upward revision for December (more coverage...
Source: ThinkstockZoetis Inc. (NYSE: ZTS), a spin-off of the animal health business of Pfizer Inc. (NYSE: PFE), held its initial public offering this morning. The company offered 86.1 million shares...